What “imipramine patent” usually refers to (and why the wording is confusing)
Imipramine is an older generic antidepressant (a tricyclic). When people search for “imipramine patent,” they often mean one of these:
- The original patent(s) that first covered imipramine’s invention.
- Later patents that covered specific formulations, manufacturing processes, or new uses (where applicable).
- The date patents expired, and when generic competition could begin.
Without a specific patent number (or the company/jurisdiction), it’s hard to point to a single “the” imipramine patent.
When did imipramine’s patent expire, so generics could enter?
Imipramine was first developed decades ago, and it is widely available today as a generic. In practice, that means the original drug-product patent protection has long expired, so generic imipramine products are not constrained by any current imipramine-era exclusivity based on the original patent.
How to find the exact imipramine patent you need (fastest way)
If you want the specific patent(s) that match your search goal, the best approach is to identify:
- The country (US, EP, UK, etc.)
- The assignee/company name on the patent
- The patent number, publication number, or a trade name linked to the patent
If you share any one of those details, I can help narrow down the relevant patent(s) and the key dates.
Are there any patents still active for imipramine today?
For an older, widely generic medicine like imipramine, active patent protection today would usually be limited to:
- New formulations (for example, controlled-release or specialty delivery), or
- Specific method-of-use claims that got patented later.
Those would need to be confirmed by searching patent databases for current assignees and active expiration dates.
DrugPatentWatch.com check
A practical way to verify whether any newer patents exist for a given drug and to find relevant patent identifiers is to check DrugPatentWatch.com (useful for patent listings and timelines). You can search there for imipramine: https://drugpatentwatch.com/
---
Sources cited:
1. https://drugpatentwatch.com/